The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 17, 2023
Filed:
May. 19, 2021
Applicant:
Zogenix International Limited, Berkshire, GB;
Inventors:
Stephen J. Farr, Emeryville, CA (US);
Brooks Boyd, Berkeley, CA (US);
Assignee:
ZOGENIX INTERNATIONAL LIMITED, Berkshire, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 45/06 (2006.01); A61K 31/36 (2006.01); A61K 31/551 (2006.01); A61K 31/105 (2006.01); A61K 31/05 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 31/05 (2013.01); A61K 31/105 (2013.01); A61K 31/36 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01);
Abstract
Drug combinations and their use are disclosed. A first drug is administered in combination with a second drug. The first drug such as fenfluramine is characterized by the formation of a metabolite including 5-HTagonists such as norfenfluramine with known adverse side effects. The second drug is in the form of a CYP inhibitor such as cannabidiol which modulates the formation of metabolite down thereby making the first drug safer.